Navigation Links
A Gene Associated With Severe Kidney Failure in Diabetes Found

Diabetes is the leading cause of end-stage kidney disease worldwide, an illness that requires either kidney dialysis treatments or a kidney transplant for survival. //

A research team at Wake Forest University Baptist Medical Center and the University of Heidelberg has proven that a gene protects some people with diabetes from developing severe kidney failure or "end-stage renal disease."

The carnosinase 1 gene, located on human chromosome 18, produces the protective factor, said Barry I. Freedman, M.D., the John H. Felts III Professor and head of the Section on Nephrology, in an article in Nephrology Dialysis Transplantation published online.

"This is a major gene that appears to be associated with development of severe diabetic kidney disease," he said.

The research team evaluated 858 subjects, including diabetic patients with end-stage kidney failure on dialysis, diabetic patients with normal kidney function, and healthy non-diabetic individuals. They confirmed that a protective form of the carnosinase 1 gene was present in greater frequency among both healthy individuals and diabetic subjects without kidney disease, compared to the diabetic patients on dialysis who more commonly had forms of the gene that were not protective.

This discovery may lead to novel treatment strategies in susceptible diabetic patients to protect them from kidney failure and may provide a marker to determine which diabetic patients are at increased risk for future kidney disease, Freedman said.

The carnosinase 1 gene produces an enzyme called carnosinase. Carnosinase inactivates the protective substance carnosine. Carnosine appears to prevent scarring from developing in kidney tissue and serves as a scavenger of damaging oxygen-free radicals.

"Prior to these genetic analyses, kidney doctors were unaware that this pathway played an important role in diabetic kidney disease," Freedman said.

He added that the
'"/>




Page: 1 2

Related medicine news :

1. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. Associated therapy for multiple myeloma
4. Associated scan for detecting ovarian cancer spread
5. Ginseng Associated with Pregnancy Risks
6. Enzyme Associated with Memory
7. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press
8. Enzyme Associated With Memory
9. Problems Associated With Iron Deficiency
10. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
11. Young Patients On Antidepressants Found To Be Associated With Suicidal Tendencies
Post Your Comments:
(Date:12/2/2008)...ll/ -- Quest Diagnostics Incorporated (NYSE: DGX...ting, information and services, announced that it ...are Conference in New York City today, December 2,...duled to begin at 4:00 p.m. Eastern Time. , ...irm its 2008 guidance for revenue growth of greate...
(Date:12/2/2008)... December 1, 2008, issue of Clinical Cancer Resea...ncer Research, show lapatinib benefits women with ...-negative breast cancer or those who express EGRF ...a misclassification of metastatic breast cancer pa...le from receiving optimal therapy. , Lapatinib,...
(Date:12/2/2008)..., Cost and Energy Efficient Information Infrastruc...re/ -- EMC Corporation (NYSE: EMC ), the world l...ay announced that the Daughters of Charity Health ...spanning the California coast, has consolidated st...ity functions to deliver new online clinical syste...
(Date:12/2/2008)...Emdeon, a leading provider of,revenue and payment...ustry,announced today the launch of an important...are. Emdeon unveiled the U.S. Healthcare Efficienc...blish a national reference for,tracking and measu...ased,system to an electronic one. , "Throu...
Breaking Medicine News(10 mins):Health News:Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference 2Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 3Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 4Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 2Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 4
...ple in a Tamil Nadu village and over 60 doctors ar...tes complications.// A medical technology company,... with the Tirunelveli Medical College at the Ariya...ere. "At present, there is little testing done to...
...have been on an all time high in the United Kingdo...n the rising temperature and pollution levels. //A...iod from 15th to 19th July, the temperatures were ...gen dioxide pollution, which is known to trigger a...
...n their way home after a month-long training in tr...nt in India will surely help improve life in war-t...mastered will help my people in Iraq," Wafa Esmaee...from Bangalore, where she was among 43 Iraqis who ...
...n developed by Georgia Tech researchers to decode ...s with other cells and reacts //to a broad spectru...ld help to better create drugs that are capable of...g human diseases. Most sophisticated tools curren...
Other Medicine News:Health News:Villagers in Tamil Nadu Take Part in Diabetes Pilot Project 2Health News:Sensor Images Show Soaring Temperature and Pollution Levels in UK 2Health News:Yoga and Meditation Comes in Aid of Iraqis to Rid of Trauma 2Health News:Yoga and Meditation Comes in Aid of Iraqis to Rid of Trauma 3Health News:Cell Behavior Better Understood with Nano Probe 2Health News:Cell Behavior Better Understood with Nano Probe 3
(Date:11/26/2008)...26 Children whose eyes ...tly increased risk of developing mental illness by... Clinic study published this month in Pediatrics ,...ediatrics. , , The retrospective study exam...bismus (misaligned eyes) and compared them with re...
(Date:11/25/2008)...5 Kleinert Kutz and Un...e fifth U.S. hand transplant on Messina, New York ...ish Hospital Hand Care Center on Monday, November ...d was completed shortly after 9 p.m. in a record n....com/cgi-bin/prnh/20081125/DC48555-a ) , (Photo...
(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 1Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 2Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 3Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 1Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 1New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 3New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 4New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 5Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 1Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 2Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 3Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 4
...s.--(BUSINESS WIRE)--Apr 12, 2007 - CombinatoRx,I...osters related,to its oncology research efforts wi...American Association for Cancer Research,April 14...ng of Targeted Chemical Combinations for,Cancer Th...resented,on Sunday, April 15, 1-5pm PT and "Synerg...
...ion pyridopyrazine-urea derivative compound series... be valuable for,cancer treatment, QUEBEC, April 1...Inc. , a global, pure play biopharmaceutical compa...y presented an abstract,outlining first in vitro d...lectivity for PI3K inhibition, at the American,Ass...
Other Medicine Technology:CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 2CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 3AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3
These precision 4mL PYREX volumetric pipets are manufactured and calibrated "To Contain" (TC - bottom line) and "To Deliver" (TD - top line) to specifications for Class A volumetric ware. Pipets are
The new Finnpipette Focus from Thermo Labsystems was designed specifically to combine ergonomics with uncompromising performance. The new interchangeable handle plate offers a custom fit for differe
Inquire
A fixed pipette is ideal for repeated pipetting of a single volume. Fixed volume FInnpipettes offer the same features and advantages as other Finnpipette Digital pipettes: New, streamlined design, S
Medicine Products: